A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis

BACKGROUND: Systemic atopic dermatitis treatments that have acceptable safety are needed. OBJECTIVE: To evaluate the safety of the oral Janus kinase inhibitor upadacitinib in combination with topical corticosteroids (TCSs) for the treatment of atopic dermatitis. METHODS: In this phase 3, double-blin...

Descripción completa

Detalles Bibliográficos
Autores principales: Katoh, Norito, Ohya, Yukihiro, Murota, Hiroyuki, Ikeda, Masanori, Hu, Xiaofei, Ikeda, Kimitoshi, Liu, John, Sasaki, Takuya, Chu, Alvina D., Teixeira, Henrique D., Saeki, Hidehisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693619/
https://www.ncbi.nlm.nih.gov/pubmed/34988493
http://dx.doi.org/10.1016/j.jdin.2021.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693619/
https://www.ncbi.nlm.nih.gov/pubmed/34988493
http://dx.doi.org/10.1016/j.jdin.2021.11.001

Ejemplares similares